Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1153 to 1160 of 1160 entries
Sorted by: Best Match Show Resources per page
A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15.

The Journal of experimental medicine

Patsalos A, Halasz L, Medina-Serpas MA, Berger WK, Daniel B, Tzerpos P, Kiss M, Nagy G, Fischer C, Simandi Z, Varga T, Nagy L.
PMID: 34846534
J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20210420. Epub 2021 Nov 30.

Muscle regeneration is the result of the concerted action of multiple cell types driven by the temporarily controlled phenotype switches of infiltrating monocyte-derived macrophages. Pro-inflammatory macrophages transition into a phenotype that drives tissue repair through the production of effectors...

Cite
Patsalos A, Halasz L, Medina-Serpas MA, et al. A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. J Exp Med. 2021;219(1)doi: 10.1084/jem.20210420.
Patsalos, A., Halasz, L., Medina-Serpas, M. A., Berger, W. K., Daniel, B., Tzerpos, P., Kiss, M., Nagy, G., Fischer, C., Simandi, Z., Varga, T., & Nagy, L. (2022). A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. The Journal of experimental medicine, 219(1), . https://doi.org/10.1084/jem.20210420
Patsalos, Andreas, et al. "A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15." The Journal of experimental medicine vol. 219,1 (2022). doi: https://doi.org/10.1084/jem.20210420
Patsalos A, Halasz L, Medina-Serpas MA, Berger WK, Daniel B, Tzerpos P, Kiss M, Nagy G, Fischer C, Simandi Z, Varga T, Nagy L. A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. J Exp Med. 2022 Jan 03;219(1). doi: 10.1084/jem.20210420. Epub 2021 Nov 30. PMID: 34846534; PMCID: PMC8635277.
Copy Download .nbib Format: NLM
Pain Management Following Otological Surgery: A Prospective Study of Different Strategies.

The Laryngoscope

Dahm V, Lui JT, Chen JM, Kiss A, Hamour AF, Le TN, Lin VY.
PMID: 34495556
Laryngoscope. 2021 Sep 08; doi: 10.1002/lary.29845. Epub 2021 Sep 08.

OBJECTIVES: The aim of this study was to prospectively assess pain and associated analgesic consumption after otological surgery comparing two prescription patterns.STUDY DESIGN: A prospective nonrandomized consecutive cohort study.METHODS: 125 adult patients undergoing ambulatory otologic surgery-cochlear implantation and endaural...

Cite
Dahm V, Lui JT, Chen JM, et al. Pain Management Following Otological Surgery: A Prospective Study of Different Strategies. Laryngoscope. 2021;doi: 10.1002/lary.29845.
Dahm, V., Lui, J. T., Chen, J. M., Kiss, A., Hamour, A. F., Le, T. N., & Lin, V. Y. (2021). Pain Management Following Otological Surgery: A Prospective Study of Different Strategies. The Laryngoscope, . https://doi.org/10.1002/lary.29845
Dahm, Valerie, et al. "Pain Management Following Otological Surgery: A Prospective Study of Different Strategies." The Laryngoscope vol. (2021). doi: https://doi.org/10.1002/lary.29845
Dahm V, Lui JT, Chen JM, Kiss A, Hamour AF, Le TN, Lin VY. Pain Management Following Otological Surgery: A Prospective Study of Different Strategies. Laryngoscope. 2021 Sep 08; doi: 10.1002/lary.29845. Epub 2021 Sep 08. PMID: 34495556.
Copy Download .nbib Format: NLM
Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations -Preliminary data.

Clinical hemorheology and microcirculation

Turchanyi B, Korei C, Somogyi V, Kiss F, Peto K, Nemeth N.
PMID: 34420941
Clin Hemorheol Microcirc. 2021 Aug 19; doi: 10.3233/CH-211200. Epub 2021 Aug 19.

BACKGROUND: Ischemia-reperfusion (I/R) may worsen blood rheology that has been demonstrated by clinical and experimental data. It is also known that anti-inflammatory agents and preconditioning methods may reduce I/R injury.OBJECTIVE: We aimed to analyze hemorheological alterations in elective knee...

Cite
Turchanyi B, Korei C, Somogyi V, et al. Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations -Preliminary data. Clin Hemorheol Microcirc. 2021;doi: 10.3233/CH-211200.
Turchanyi, B., Korei, C., Somogyi, V., Kiss, F., Peto, K., & Nemeth, N. (2021). Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations -Preliminary data. Clinical hemorheology and microcirculation, . https://doi.org/10.3233/CH-211200
Turchanyi, Bela, et al. "Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations -Preliminary data." Clinical hemorheology and microcirculation vol. (2021). doi: https://doi.org/10.3233/CH-211200
Turchanyi B, Korei C, Somogyi V, Kiss F, Peto K, Nemeth N. Beneficial postoperative micro-rheological effects of intraoperative administration of diclophenac or ischemic preconditioning in patients with lower extremity operations -Preliminary data. Clin Hemorheol Microcirc. 2021 Aug 19; doi: 10.3233/CH-211200. Epub 2021 Aug 19. PMID: 34420941.
Copy Download .nbib Format: NLM
Revisiting mouse minute virus inactivation by high temperature short time treatment.

Biotechnology and bioengineering

Su J, Rice J, Hoffman J, Alvarado S, Bailey M, Kopp M, Murphy M, Kiss R, Barone PW, Wiebe ME, Springs SL, Dehghani H, Chen D.
PMID: 33913515
Biotechnol Bioeng. 2021 Aug;118(8):2967-2976. doi: 10.1002/bit.27805. Epub 2021 Jun 08.

In recent years, high temperature short time (HTST) treatment technology has been increasingly adopted for medium treatment to mitigate the potential risk of viral contamination in mammalian cell culture GMP manufacturing facilities. Mouse minute virus (MMV), also called minute...

Cite
Su J, Rice J, Hoffman J, et al. Revisiting mouse minute virus inactivation by high temperature short time treatment. Biotechnol Bioeng. 2021;118(8):2967-2976doi: 10.1002/bit.27805.
Su, J., Rice, J., Hoffman, J., Alvarado, S., Bailey, M., Kopp, M., Murphy, M., Kiss, R., Barone, P. W., Wiebe, M. E., Springs, S. L., Dehghani, H., & Chen, D. (2021). Revisiting mouse minute virus inactivation by high temperature short time treatment. Biotechnology and bioengineering, 118(8), 2967-2976. https://doi.org/10.1002/bit.27805
Su, Joleen, et al. "Revisiting mouse minute virus inactivation by high temperature short time treatment." Biotechnology and bioengineering vol. 118,8 (2021): 2967-2976. doi: https://doi.org/10.1002/bit.27805
Su J, Rice J, Hoffman J, Alvarado S, Bailey M, Kopp M, Murphy M, Kiss R, Barone PW, Wiebe ME, Springs SL, Dehghani H, Chen D. Revisiting mouse minute virus inactivation by high temperature short time treatment. Biotechnol Bioeng. 2021 Aug;118(8):2967-2976. doi: 10.1002/bit.27805. Epub 2021 Jun 08. PMID: 33913515.
Copy Download .nbib Format: NLM
Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis.

Journal of personalized medicine

Imrei M, Németh D, Szakács Z, Hegyi P, Kiss S, Alizadeh H, Dembrovszky F, Pázmány P, Bajor J, Párniczky A.
PMID: 34575636
J Pers Med. 2021 Aug 28;11(9). doi: 10.3390/jpm11090859.

OBJECTIVES: Immune regulation seems to be altered in cystic fibrosis (CF), thus potentially predisposing patients to developing autoimmune diseases (AID). In this meta-analysis, we aimed to evaluate the prevalence of celiac disease (CeD) among CF patients as by far...

Cite
Imrei M, Németh D, Szakács Z, et al. Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis. J Pers Med. 2021;11(9)doi: 10.3390/jpm11090859.
Imrei, M., Németh, D., Szakács, Z., Hegyi, P., Kiss, S., Alizadeh, H., Dembrovszky, F., Pázmány, P., Bajor, J., & Párniczky, A. (2021). Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis. Journal of personalized medicine, 11(9), . https://doi.org/10.3390/jpm11090859
Imrei, Marcell, et al. "Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis." Journal of personalized medicine vol. 11,9 (2021). doi: https://doi.org/10.3390/jpm11090859
Imrei M, Németh D, Szakács Z, Hegyi P, Kiss S, Alizadeh H, Dembrovszky F, Pázmány P, Bajor J, Párniczky A. Increased Prevalence of Celiac Disease in Patients with Cystic Fibrosis: A Systematic Review and Meta-Analysis. J Pers Med. 2021 Aug 28;11(9). doi: 10.3390/jpm11090859. PMID: 34575636; PMCID: PMC8470465.
Copy Download .nbib Format: NLM
Differentiating sepsis from similar groups of symptoms at triage level in emergency care.

Physiology international

Molnár G, Gyarmathy VA, Takács J, Sándor S, Kiss B, Fazakas J, Kanizsai PL.
PMID: 33769958
Physiol Int. 2021 Mar 24; doi: 10.1556/2060.2021.00005. Epub 2021 Mar 24.

OBJECTIVES: Conditions that have similar initial presentations as sepsis may make early recognition of sepsis in an emergency room (ER) difficult. We investigated whether selected physiologic and metabolic parameters can be reliably used in the emergency department to differentiate...

Cite
Molnár G, Gyarmathy VA, Takács J, et al. Differentiating sepsis from similar groups of symptoms at triage level in emergency care. Physiol Int. 2021;doi: 10.1556/2060.2021.00005.
Molnár, G., Gyarmathy, V. A., Takács, J., Sándor, S., Kiss, B., Fazakas, J., & Kanizsai, P. L. (2021). Differentiating sepsis from similar groups of symptoms at triage level in emergency care. Physiology international, . https://doi.org/10.1556/2060.2021.00005
Molnár, G, et al. "Differentiating sepsis from similar groups of symptoms at triage level in emergency care." Physiology international vol. (2021). doi: https://doi.org/10.1556/2060.2021.00005
Molnár G, Gyarmathy VA, Takács J, Sándor S, Kiss B, Fazakas J, Kanizsai PL. Differentiating sepsis from similar groups of symptoms at triage level in emergency care. Physiol Int. 2021 Mar 24; doi: 10.1556/2060.2021.00005. Epub 2021 Mar 24. PMID: 33769958.
Copy Download .nbib Format: NLM
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials.

Scientific reports

Kiss S, Gede N, Hegyi P, Nagy B, Deák R, Dembrovszky F, Bunduc S, Erőss B, Leiner T, Szakács Z, Alizadeh H.
PMID: 34754015
Sci Rep. 2021 Nov 09;11(1):21916. doi: 10.1038/s41598-021-01440-x.

Daratumumab has shown clinical benefit in multiple myeloma. We aimed to evaluate the safety and efficacy of adding daratumumab to backbone anti-myeloma treatments. Systematic search was performed up to August 2021 to identify randomised controlled trials comparing the outcomes...

Cite
Kiss S, Gede N, Hegyi P, et al. Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials. Sci Rep. 2021;11(1):21916doi: 10.1038/s41598-021-01440-x.
Kiss, S., Gede, N., Hegyi, P., Nagy, B., Deák, R., Dembrovszky, F., Bunduc, S., Erőss, B., Leiner, T., Szakács, Z., & Alizadeh, H. (2021). Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials. Scientific reports, 11(1), 21916. https://doi.org/10.1038/s41598-021-01440-x
Kiss, Szabolcs, et al. "Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials." Scientific reports vol. 11,1 (2021): 21916. doi: https://doi.org/10.1038/s41598-021-01440-x
Kiss S, Gede N, Hegyi P, Nagy B, Deák R, Dembrovszky F, Bunduc S, Erőss B, Leiner T, Szakács Z, Alizadeh H. Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials. Sci Rep. 2021 Nov 09;11(1):21916. doi: 10.1038/s41598-021-01440-x. PMID: 34754015; PMCID: PMC8578422.
Copy Download .nbib Format: NLM
Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma.

Journal of clinical medicine

Bozsányi S, Varga NN, Farkas K, Bánvölgyi A, Lőrincz K, Lihacova I, Lihachev A, Plorina EV, Bartha Á, Jobbágy A, Kuroli E, Paragh G, Holló P, Medvecz M, Kiss N, Wikonkál NM.
PMID: 35011930
J Clin Med. 2021 Dec 30;11(1). doi: 10.3390/jcm11010189.

Breslow thickness is a major prognostic factor for melanoma. It is based on histopathological evaluation, and thus it is not available to aid clinical decision making at the time of the initial melanoma diagnosis. In this work, we assessed...

Cite
Bozsányi S, Varga NN, Farkas K, et al. Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010189.
Bozsányi, S., Varga, N. N., Farkas, K., Bánvölgyi, A., Lőrincz, K., Lihacova, I., Lihachev, A., Plorina, E. V., Bartha, �. �., Jobbágy, A., Kuroli, E., Paragh, G., Holló, P., Medvecz, M., Kiss, N., & Wikonkál, N. M. (2021). Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010189
Bozsányi, Szabolcs, et al. "Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010189
Bozsányi S, Varga NN, Farkas K, Bánvölgyi A, Lőrincz K, Lihacova I, Lihachev A, Plorina EV, Bartha Á, Jobbágy A, Kuroli E, Paragh G, Holló P, Medvecz M, Kiss N, Wikonkál NM. Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma. J Clin Med. 2021 Dec 30;11(1). doi: 10.3390/jcm11010189. PMID: 35011930; PMCID: PMC8745435.
Copy Download .nbib Format: NLM
Showing 1153 to 1160 of 1160 entries